Samik Pharmaceutical Company LTD. (KOSDAQ:014950)
South Korea · Delayed Price · Currency is KRW
9,760.00
-1,000.00 (-9.29%)
At close: Apr 2, 2026
KOSDAQ:014950 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
|---|
| -754.89 | 3,522 | 2,969 |
Depreciation & Amortization | 1,376 | 1,351 | 1,278 |
Loss (Gain) From Sale of Assets | -45.98 | -9.5 | -0.07 |
Asset Writedown & Restructuring Costs | - | 23.8 | - |
Loss (Gain) From Sale of Investments | -348.99 | -300.14 | -298.32 |
| 122.88 | 263.58 | 72.69 |
Provision & Write-off of Bad Debts | -22.41 | -2.68 | -65.12 |
Other Operating Activities | 5,084 | 1,391 | 696.68 |
Change in Accounts Receivable | 3,825 | 558.63 | -1,117 |
| -3,212 | -2,105 | -55.64 |
Change in Accounts Payable | -3,343 | 251.69 | -827.43 |
| - | - | -3.98 |
Change in Other Net Operating Assets | -604.02 | -559.9 | -400.44 |
| 2,077 | 4,385 | 2,248 |
Operating Cash Flow Growth | -52.64% | 95.04% | - |
| -3,423 | -842.32 | -1,374 |
| 187.9 | - | - |
Sale (Purchase) of Intangibles | -8.69 | -5.83 | -3.14 |
| 2,267 | -1,613 | -120.5 |
Other Investing Activities | -21.95 | - | -70 |
| -1,153 | -2,161 | -1,868 |
| -85.93 | -137.56 | -109.02 |
| -85.93 | -137.56 | -109.02 |
| 131.66 | 672.3 | - |
Repurchase of Common Stock | -15.73 | - | - |
| -285.97 | -281 | -140.5 |
Other Financing Activities | - | -1.02 | - |
| -255.98 | 252.72 | -249.52 |
Foreign Exchange Rate Adjustments | 1.28 | - | - |
Miscellaneous Cash Flow Adjustments | - | - | -0 |
| 669.13 | 2,477 | 130.88 |
| -1,346 | 3,543 | 874.05 |
| - | 305.32% | - |
| -2.24% | 6.34% | 1.71% |
| -176.56 | 503.91 | 124.52 |
| 8.99 | 12.04 | 18.36 |
| 599.17 | 205.69 | 3.03 |
| -2,343 | 3,382 | - |
| -2,325 | 3,389 | - |
Change in Working Capital | -3,334 | -1,854 | -2,405 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.